Martingale Asset Management L P Natera, Inc. Transaction History

Martingale Asset Management L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$36.57 - $58.29 $106,162 - $169,215	-2,903 Reduced 39.75%	4,401 $244,000
Q4 2022 Feb 13, 2023	SELL	$34.17 - $47.91 $6,697 - $9,390	-196 Reduced 2.61%	7,304 $293,000
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $276,975 - $425,100	7,500 New	7,500 $329,000
Q2 2021 Aug 13, 2021	SELL	$86.05 - $119.72 $405,639 - $564,360	-4,714 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$91.47 - $124.36 $100,617 - $136,796	1,100 Added 30.44%	4,714 $478,000
Q4 2020 Feb 10, 2021	BUY	$66.66 - $111.74 $240,909 - $403,828	3,614 New	3,614 $359,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.